Drug hope for acute myeloid leukemia

August 8, 2017, University of Bradford
Professor Richard Morgan, Director, Institute of Cancer Therapeutics, University of Bradford, UK. Credit: University of Bradford

A new drug that strips cancer cells of their "immortality" could help to treat patients suffering from one of the most aggressive forms of leukaemia.

The drug candidate, called HXR9, works by preventing the cancer cells from sidestepping the natural process that causes unhealthy and to die, known as apoptosis.

Researchers at the University of Bradford have found the drug could be used to treat (AML), which is responsible for 2,500 deaths in the UK and 265,000 worldwide each year.

The drug targets a particular family of genes, called HOX genes, which are involved in controlling the rapid growth of cells. In adults these are switched off but in cancer cells they can be turned back on. This helps to give the cancer cells the ability to continuously grow and divide by circumventing the normal mechanisms that trigger apoptosis - effectively making them immortal.

Professor Richard Morgan, Director of the Institute for Cancer Therapeutics at the University of Bradford who led the research, said HXR9 strips the cancer cells of this ability by turning off the HOX genes.

He said: "Acute myeloid leukaemia is a pretty intractable disease and doesn't respond to many treatments. This is a novel therapeutic target that hasn't been shown before to be effective against this form of leukaemia."

Previously, Professor Morgan and his colleagues have shown that HRX9 could potentially be used to treat solid cancer tumours like in prostate cancer. They are currently preparing for a clinical trial due to being next year, where a form of HRX9 will be given to cancer patients who have failed to respond to other types of treatment.

In the latest study, which is published in the journal Oncotarget, the researchers wanted to see if the same drug could be used to treat difficult to treat blood cancers.

They analysed from 269 AML patients and found an association between the activity of a group of HOX genes and the patient survival rate.

Professor Morgan and his team then tested HXR9 on taken from patients suffering from AML and found it caused the cancer cells to undergo a process known as necroptosis.

Necroptosis causes the cells to explode and spew their contents into the bloodstream rather than simply digesting themselves as normally occurs in apoptosis. This increases the likelihood that there will be a subsequent immune reaction against the , according to Professor Morgan.

The researchers found that when they combined HXR9 with another , a protein kinase C inhibitor called Ro31, it enhanced the reduction in growth even further.

"It could well be used in combination treatments but the initial trials will be as a single therapy," said Professor Morgan.

Explore further: New drug hope for mesothelioma

More information: Oncotarget, www.impactjournals.com/oncotar … ]=20023&path[]=63885

Related Stories

New drug hope for mesothelioma

March 14, 2016
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.

Gene signature in ovarian cancer predicts survival and offers new drug target

June 28, 2016
A new UK study has identified a gene signature that predicts poor survival from ovarian cancer. The study also identified genes which help the cancer develop resistance to chemotherapy - offering a new route to help tackle ...

Cell mechanism discovery could lead to 'fundamental' change in leukaemia treatment

July 27, 2017
Researchers have identified a new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukaemia.

New drug combination shows promise for resistant leukaemia

May 18, 2016
Patients with acute myeloid leukaemia (AML) can look forward to the development of new therapies following the discovery by Walter and Eliza Hall Institute researchers of a new way to kill cells that are dangerously multiplying.

Study leads to breakthrough in better understanding acute myeloid leukemia

May 23, 2017
A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.

Researchers identify new protein linked to leukaemia growth

May 16, 2014
(Medical Xpress)—Their work has identified a protein called PIP4K2A that could be a new target in drug development.

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.